11 transactions on file, per SEC Form 4 filings.
See NTRA superinvestor activity →Rabinowitz Matthew
EXECUTIVE CHAIRMAN · 2026-09-11
Sold
$260K
Rabinowitz Matthew
EXECUTIVE CHAIRMAN · 2026-09-11
Sold
$1.2M
Rabinowitz Matthew
EXECUTIVE CHAIRMAN · 2026-09-11
Sold
$3.5M
Rabinowitz Matthew
EXECUTIVE CHAIRMAN · 2026-09-11
Sold
$5.9M
Rabinowitz Matthew
EXECUTIVE CHAIRMAN · 2026-09-11
Sold
$5.2M
Rabinowitz Matthew
EXECUTIVE CHAIRMAN · 2026-09-11
Sold
$429K
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS · 2026-09-02
Sold
$5.0M
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS · 2026-09-01
Sold
$320K
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS · 2026-09-01
Sold
$449K
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS · 2026-09-01
Sold
$193K
Chapman Steven Leonard
CEO AND PRESIDENT · 2026-09-01
Sold
$545K
Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.
Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.
Analyze NTRA